News All PostNewsAxxam, leadXpro and MercachemSyncom Form a Strategic Alliance for Structure-based Drug Discovery Services28 October 2020read more >Axxam and FUJIFILM Cellular Dynamics announce strategic alliance to deliver integrated hiPSC drug discovery solutions8 October 2020read more >Axxam announces the launch of Libra Therapeutics to develop novel therapies targeting neurodegenerative diseases24 September 2020read more >Selonterra and Axxam Enter into Drug Discovery Collaboration16 June 2020read more >Axxam enters into Drug Discovery Collaboration with Vivozon for CNS Indications12 May 2020read more >Axxam supports drug discovery efforts to identify novel inhibitors for SARS-CoV-230 April 2020read more >Load MoreEnd of Content.
Axxam, leadXpro and MercachemSyncom Form a Strategic Alliance for Structure-based Drug Discovery Services28 October 2020read more >
Axxam and FUJIFILM Cellular Dynamics announce strategic alliance to deliver integrated hiPSC drug discovery solutions8 October 2020read more >
Axxam announces the launch of Libra Therapeutics to develop novel therapies targeting neurodegenerative diseases24 September 2020read more >
Axxam enters into Drug Discovery Collaboration with Vivozon for CNS Indications12 May 2020read more >
Axxam supports drug discovery efforts to identify novel inhibitors for SARS-CoV-230 April 2020read more >